Approximately half of high-grade ovarian cancers are characterized by genetic and epigenetic alterations of genes involved in homologous recombination (HRR), most commonly BRCA1 and BRCA2. HRR defects identified by tests of genomic instability confer PARP-inhi... ...

请注册登录后继续浏览